Febrile reactions occurring with second cycle of high-dose melphalan and SCT in patients with AL amyloidosis: a ‘melphalan recall’ reaction

Por Rosenzweig, M, Seldin, DC, Remick, DG, Skinner, M, Quillen, K, Oran, B, Finn, KT, Sanchorawala, V
Publicado em 2009

Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115

Por Sanchorawala, V, Hoering, A, Seldin, DC, Finn, KT, Fennessey, SA, Sexton, R, Mattar, B, Safah, HF, Holmberg, LA, Dean, RM, Orlowski, RZ, Barlogie, B
Publicado em 2013